RxDoctor Payments Data

Chad Gonzales, MD

Gastroenterology · Ogden, UTNPI 1669447801

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $14,900 of the $24,666 with a category attached, or 60.4%. 28 manufacturers reported payments, led by AbbVie at 51.1% of the total. Reporting peaked in 2019 at $11,336 and has fallen 96.7% since, to $373 in 2025. Among gastroenterology clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$24,666in general payments, 2019–2025

Across 361 payments — averaging $68.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$13K
  • Pfizer$4K
  • Eli Lilly Export S.A. Puerto Rico Branch$4K
  • Eli Lilly$1K
  • Takeda Pharmaceuticals U.S.A., Inc.$956
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$363
  • plus $1K from 22 others
$2,878,583in research payments, 2019–2025

Across 321 payments — averaging $8967.55 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$1.5M
  • Bristol Myers Squibb$676K
  • Janssen Research & Development, LLC$132K
  • E.r. Squibb & Sons, L.L.C.$131K
  • Chugai Pharmaceutical Co., Ltd.$130K
  • AbbVie$90K
  • plus $201K from 5 others

What the payments were for

  • Consulting fees$3,75015%
  • Speaking & faculty fees$14,90060%
  • Travel & lodging$1,1795%
  • Food & beverage$4,75619%
  • Education$810%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$24,666 in reported general payments places this provider in the 95th percentile of 122 gastroenterology providers in Utah.

See all gastroenterology providers in Utah

Medicare billing

Part B allowed, 2024
$97,880
Medicare patients
416
Services billed
650

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates69$4,465
Omeprazole219$2,842
Sucralfate25$1,397
Budesonide DrBudesonide17$1,221
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl59$1,102
Sulfasalazine12$713
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg23$689
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl32$475
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl22$372
Famotidine29$228
Pantoprazole Sodium20$187

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Ogden

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →